Recent development of near infrared light therapy (NILT) as an acute stroke treatment is promising. In various preclinical animal stroke models, NILT has been shown to be effective in improving long-term stroke outcome. More importantly, NILT has a long postischemic therapeutic window that has not been previously observed in other treatment modalities. The preliminary efficacy and safety of NILT in acute stroke patients were demonstrated in the recently published phase II ***NeuroThera Effectiveness and Safety Trial (NEST-1). If confirmed by the NEST-II trial, ***NILT will revolutionize acute stroke management as ***ut has a long time window (possible 24 hr) for therapy. Moreover, understanding the mechanisms of action of NILT will provide a new therapeutic target for future drug or device development.
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med1995; 333:1581–7.
2.
BarberPAZhangJDemchukAMHillMDBuchanAM: Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology2001; 56:1015–20.
3.
GladstoneDJBlackSEHakimAM: Heart and Stroke Foundation of Ontario Centre of Excellence in Stroke Recovery. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke2002; 33:2123–36.
4.
SavitzSIFisherM: Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials. Ann Neurol2007; 61:396–402.
5.
GinsbergMD: Life after cerovive: a personal perspective on ischemic neuroprotection in the post-NXY-059 era. Stroke2007; 38:1967–72.
6.
HessDC: NXY-059 a hopeful sign in the treatment of stroke. Stroke2006: 37, 2649–50.
7.
FisherM: NXY-059 for acute ischemic stroke: the promise of neuroprotection is finally realized?Stroke2006; 37:2651–2.
8.
LeesKRZivinJAAshwoodTStroke-Acute Ischemic NXY Treatment (SAINT I) Trial Investigators NXY-059 for acute ischemic stroke. N Engl J Med2006: 354, 588–600.
9.
Shuaib A, Lees KRSAINT II Trial Investigators et al.NXY-059 for the treatment of acute ischemic stroke. N Engl J Med2007; 357:562–71.
10.
Stroke Therapy Academic Industry Roundtable II (STAIR-II): Recommendations for clinical trial evaluation of acute stroke therapies. Stroke2001: 32, 1598–606.
11.
LamplYZivinJAFisherMInfrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1). Stroke2007; 38:1843–9.
12.
WarburgO: The effect of carbon monoxide on the metabolism of yeast. Biochem Z1926; 177:471–86.
13.
AilioaieCLupusoru-AilioaieLM: Beneficial effects of laser therapy in the early stages of rheumatoid arthritis onset. J Laser Ther1999; 11:79–87.
14.
MesterEMesterAFMesterA: The biomedical effects of laser application. Lasers Surg Med1985; 5:31–9.
15.
LeeGWongEMasonDT: New concepts in pain management and in the application of low-power laser for relief of cervicothoracic pain syndromes. Am Heart J1996; 132:1329–34.
16.
IrvineJChongSLAmirjaniNChanKM: Double-blind randomized controlled trial of low-level laser therapy in carpal tunnel syndrome. Muscle Nerve2004; 30:182–7.
17.
NaeserMAHahnKALiebermanBEBrancoKF: Carpal tunnel syndrome pain treated with low-level laser and microamperes transcutaneous electric nerve stimulation: a controlled study. Arch Phys Med Rehabil2002; 83:978–88.
18.
EvcikDKavuncuVCakirTSubashiVYamanM.: Laser therapy in the treatment of carpal tunnel syndrome: a randomized controlled trial. Photomed Laser Surg2007; 25:34–9.
19.
BjordalJ.: Letter to the editor: inadequate statistical analysis hides significant effect of low level laser therapy in carpel tunnel syndrome. Photomed Laser Surg2007; 25:530–1.
20.
PiazziniDBAprileIFerraraPEA systematic review of conservative treatment of carpal tunnel syndrome. Clin Rehabil2007; 21:299–314.
21.
BrosseauLWelchVWellsGLow level laser therapy (classes I, II and III) for treating osteoarthritis. Cochrane Database Syst Rev2004; CD002046.
22.
BrosseauLRobinsonVWellsGLow level laser therapy (classes I, II and III) for treating rheumatoid arthritis. Cochrane Database Syst Rev2005; CD002049.
23.
PostenWWroneDADoverJS: Low-level laser therapy for wound healing: mechanism and efficacy. Dermatol Surg2005; 31:334–40.
24.
ConlanMJRapleyJWCobbCM: Biostimulation of wound healing by low-energy laser irradiation. A review. J Clin Periodontol1996: 23, 492–6.
25.
StreeterJDe TaboadaLOronU: Mechanisms of action of light therapy for stroke and acute myocardial infarction. Mitochondrion2004; 4:569–76.
26.
Mochizuki-OdaNKataokaTCuiYYamadaHHeyaMAwazuK: Effects of near-infra-red laser irradiation on adenosine triphosphate and adenosine diphosphate contents of rat brain tissue. Neurosci Lett2002; 323:207–10.
27.
OronUIlicSDe TaboadaLStreeterJ: Ga-As (808 nm) laser irradiation enhances ATP production in human neuronal cells in culture. Photomed Laser Surg2007; 25:180–2.
28.
LeungMCPLoSCLSiuFKWSoKF: Treatment of experimentally induced transient cerebral ischemia with low energy laser inhibits nitric oxide synthase activity and up-regulates the expression of transforming growth factor beta 1. Lasers Surg Med2002; 31:283–8.
29.
PinheiroALGerbiME: Photoengineering of bone repair processes. Photomed Laser Surg2006; 24:169–78.
30.
OronAOronUChenJLow-level laser therapy applied transcranially to rats after induction of stroke significantly reduces long term neurological deficits. Stroke2006; 37:2620–4.
31.
LapchakPAWeiJZivinJA: Transcranial infrared laser therapy improves clinical rating score after embolic stroke in rabbits. Stroke2004; 35:1985–8.
32.
LydenPDZivinJAClarkWATissue plasminogen activator-mediated thrombolysis of cerebral emboli and its effect on hemorrhagic infarction in rabbits. Neurology1989: 39, 703–8.
33.
ZivinJALydenPDDeGirolamiUTissue plasminogen activator. Reduction of neurologic damage after experimental embolic stroke. Arch Neurol1988; 45:387–91.
34.
LapchakPAAraujoDMPakolaSMicroplasmin: a novel thrombolytic that improves behavioral outcome after embolic strokes in rabbits. Stroke2002: 33, 2279–84.
35.
LapchakPAAraujoDMZivinJ: Comparison of tenecteplase with alteplase on clinical rating scores following small clot embolic strokes in rabbits. Exp Neurol2004; 185:154–9.
36.
ZivinJAWaudDR: Quantal bioassay and stroke. Stroke1992; 23:767–73.
37.
LapchakPASalgadoKFChaoCHZivinJA: Transcranial near infrared light therapy improves motor function following embolic strokes in rabbits; an extended therapeutic window study using continuous and pulse frequency delivery modes. Neuroscience2007; 148:907–14.
38.
De TabodaLIlicSLeichliter-MarthaSOronUOronAStreeterJ: Transcranial application of low energy laser irradiation improves neurological deficits in rats following acute stroke. Lasers Surg Med2002; 38:70–3.
39.
WiltroutCLangBYanYDempseyRJVemugantiR: Repairing brain after stroke: a review on post-ischemic neurogenesis. Neurochem Int2007; 50:1028–41.
